Led by John B. Kostis, MD, the John G. Detwiler professor of cardiology, professor of medicine and chair, department of medicine, UMDNJ-Robert Wood Johnson Medical School, this post-hoc analysis of the five-year 10,001 patient TNT study that was funded by Pfizer, Inc., was published in the May 2008 issue of the Journal of Clinical Hypertension.
“People who have both high cholesterol and high blood pressure are at greater risk for cardiovascular disease than those with either condition alone.Yet, a minority of patients with both conditions is treated to currently recommended targets. In one study less than a third of such patients were treated and only one in ten were treated to target,” said Dr. Kostis. “The analysis reported today reminds us that intensive management of both cholesterol and blood pressure, can significantly reduce the risk of heart attacks and strokes.”
Among the 10,001 patients of TNT, 9,739 who had both LDL cholesterol and systolic blood pressure measured at three months after randomization, were included in this analysis. All patients received cholesterol-lowering therapy with atorvastatin calcium (Lipitor®) 80 mg or 10 mg. More than 95 percent of patients in this analysis also were receiving antihypertensive therapy.As reported in the published analysis, patients were divided into groups based on LDL levels (73 mg/dL and lower; 74 to 94 mg/dL; or 95 mg/dL and higher) and systolic blood pressure (140 mmHg and higher, or lower than 140 mmHg) at three months. During a median follow-up of 4.9 years, patients with the lowest LDL and the lowest BP had the lowest risk of major cardiovascular events. For each of the three LDL groups, the rate of cardiovascular events was lower in patients whose systolic blood pressure (SBP) was below 140 mmHg. The benefit of SBP
“Overall, this study provides new evidence of the importance of controlling both dyslipidemia and hypertension” said Dr. Kostis. “However, controlling other risk factors, especially smoking, is still essential to reducing the risk of heart attack and stroke.”
To interview Dr. Kostis, contact Jennifer Forbes at email@example.com or 732-235-6356.
As one of the eight schools of the University of Medicine and Dentistry of New Jersey with 2,500 full-time and volunteer faculty, Robert Wood Johnson Medical School encompasses 22 basic science and clinical departments, hosts centers and institutes including The Cancer Institute of New Jersey, the Child Health Institute of New Jersey, the Center for Advanced Biotechnology and Medicine, the Environmental and Occupational Health Sciences Institute, and the Stem Cell Institute of New Jersey. The medical school maintains educational programs at the undergraduate, graduate and postgraduate levels for more than 1,500 students on its campuses in New Brunswick, Piscataway, and Camden, and provides continuing education courses for health care professionals and community education programs.
Jennifer Forbes | newswise
Researchers simplify tiny structures' construction drip by drip
12.11.2018 | Princeton University, Engineering School
Mandibular movement monitoring may help improve oral sleep apnea devices
06.11.2018 | Elsevier
Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.
Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...
Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.
In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...
On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.
When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure
Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...
Physicists at ETH Zurich demonstrate how errors that occur during the manipulation of quantum system can be monitored and corrected on the fly
The field of quantum computation has seen tremendous progress in recent years. Bit by bit, quantum devices start to challenge conventional computers, at least...
09.11.2018 | Event News
06.11.2018 | Event News
23.10.2018 | Event News
14.11.2018 | Life Sciences
14.11.2018 | Life Sciences
14.11.2018 | Earth Sciences